These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 35563721)

  • 1. Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker.
    Birmpilis AI; Paschalis A; Mourkakis A; Christodoulou P; Kostopoulos IV; Antimissari E; Terzoudi G; Georgakilas AG; Armpilia C; Papageorgis P; Kastritis E; Terpos E; Dimopoulos MA; Kalbacher H; Livaniou E; Christodoulou MI; Tsitsilonis OE
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothymosin Alpha: An Alarmin and More..
    Samara P; Karachaliou CE; Ioannou K; Papaioannou NE; Voutsas IF; Zikos C; Pirmettis I; Papadopoulos M; Kalbacher H; Livaniou E; Tsitsilonis OE; Voelter W
    Curr Med Chem; 2017; 24(17):1747-1760. PubMed ID: 28521686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of SNARE Protein Interaction for Non-classical Release of DAMPs/Alarmins Proteins, Prothymosin Alpha and S100A13.
    Matsunaga H; Halder SK; Ueda H
    Cell Mol Neurobiol; 2021 Nov; 41(8):1817-1828. PubMed ID: 32856232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications?
    Samara P; Ioannou K; Tsitsilonis OE
    Vitam Horm; 2016; 102():179-207. PubMed ID: 27450735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothymosin α and its C-Terminal Immunoreactive Decapeptide Show No Evidence of Acute Toxicity: A Preliminary
    Birmpilis AI; Vitsos P; Kostopoulos IV; Williams L; Ioannou K; Samara P; Karachaliou CE; Voutsas IF; Alyfanti E; Angelis N; Gavalas NG; Gkraikou T; Kappa N; Klagkou E; Klimentzou P; Nikou S; Papaioannou NE; Skopeliti M; Toukli D; Dimopoulos MA; Bamias A; Livaniou E; Kalbacher H; Tsitsilonis OE; Voelter W
    Curr Med Chem; 2022; 29(42):6463-6478. PubMed ID: 34789121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prothymosin α and a prothymosin α-derived peptide enhance T(H)1-type immune responses against defined HER-2/neu epitopes.
    Ioannou K; Derhovanessian E; Tsakiri E; Samara P; Kalbacher H; Voelter W; Trougakos IP; Pawelec G; Tsitsilonis OE
    BMC Immunol; 2013 Sep; 14():43. PubMed ID: 24053720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting immunogenic cell death in cancer.
    Ahmed A; Tait SWG
    Mol Oncol; 2020 Dec; 14(12):2994-3006. PubMed ID: 33179413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prothymosinα, as a neuroprotective DAMPs/Alarmins molecule].
    Ueda H; Maeda S
    Nihon Yakurigaku Zasshi; 2018; 151(1):15-19. PubMed ID: 29321391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fragment of the alarmin prothymosin α as a novel biomarker in murine models of bacteria-induced sepsis.
    Samara P; Miriagou V; Zachariadis M; Mavrofrydi O; Promponas VJ; Dedos SG; Papazafiri P; Kalbacher H; Voelter W; Tsitsilonis O
    Oncotarget; 2017 Jul; 8(30):48635-48649. PubMed ID: 28611290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothymosin-α Variants Elicit Anti-HIV-1 Response via TLR4 Dependent and Independent Pathways.
    Gusella GL; Teixeira A; Aberg J; Uversky VN; Mosoian A
    PLoS One; 2016; 11(6):e0156486. PubMed ID: 27310139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells.
    Solari JIG; Filippi-Chiela E; Pilar ES; Nunes V; Gonzalez EA; Figueiró F; Andrade CF; Klamt F
    BMC Cancer; 2020 May; 20(1):474. PubMed ID: 32456685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C-terminal decapeptide of prothymosin α is responsible for its stimulatory effect on the functions of human neutrophils in vitro.
    Samara P; Ioannou K; Neagu M; Arnogiannaki N; Ardavanis A; Voelter W; Tsitsilonis O
    Int Immunopharmacol; 2013 Jan; 15(1):50-7. PubMed ID: 23201434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific in vitro binding of a new (99m)Tc-radiolabeled derivative of the C-terminal decapeptide of prothymosin alpha on human neutrophils.
    Karachaliou CE; Liolios C; Triantis C; Zikos C; Samara P; Tsitsilonis OE; Kalbacher H; Voelter W; Papadopoulos M; Pirmettis I; Livaniou E
    Int J Pharm; 2015; 486(1-2):1-12. PubMed ID: 25796124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Immunodetection of Prothymosin Alpha in Normal and Pathological Conditions.
    Karachaliou CE; Kalbacher H; Voelter W; Tsitsilonis OE; Livaniou E
    Curr Med Chem; 2020; 27(29):4840-4854. PubMed ID: 31389310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenic Cell Death Induction by Ionizing Radiation.
    Zhu M; Yang M; Zhang J; Yin Y; Fan X; Zhang Y; Qin S; Zhang H; Yu F
    Front Immunol; 2021; 12():705361. PubMed ID: 34489957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an ELISA for the quantification of the C-terminal decapeptide prothymosin α(100-109) in sera of mice infected with bacteria.
    Samara P; Kalbacher H; Ioannou K; Radu DL; Livaniou E; Promponas VJ; Voelter W; Tsitsilonis O
    J Immunol Methods; 2013 Sep; 395(1-2):54-62. PubMed ID: 23831611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death.
    Hayashi K; Nikolos F; Lee YC; Jain A; Tsouko E; Gao H; Kasabyan A; Leung HE; Osipov A; Jung SY; Kurtova AV; Chan KS
    Nat Commun; 2020 Dec; 11(1):6299. PubMed ID: 33288764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor Reactive T-Cell Responses Are Enhanced In Vivo by DAMP Prothymosin Alpha and Its C-Terminal Decapeptide.
    Birmpilis AI; Karachaliou CE; Samara P; Ioannou K; Selemenakis P; Kostopoulos IV; Kavrochorianou N; Kalbacher H; Livaniou E; Haralambous S; Kotsinas A; Farzaneh F; Trougakos IP; Voelter W; Dimopoulos MA; Bamias A; Tsitsilonis O
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31717548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID mice.
    Voutsas IF; Pistamaltzian N; Tsiatas ML; Skopeliti M; Katsila T; Mavrothalassiti I; Spyrou S; Dimopoulos MA; Tsitsilonis OE; Bamias A
    Eur J Cancer; 2013 May; 49(7):1706-14. PubMed ID: 23276721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
    Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
    Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.